NYSE:NVO

Novo Nordisk A/s Stock News

Healthcare > Biotechnology

Buy NVO

*Your capital is at risk

$47.64

+0.230 (+0.485%)

At Close: Jun 25, 2026

Novavax to Sell Czech Manufacturing Plant to Novo Nordisk for $200M

12:55pm, Thursday, 05'th Dec 2024

NVAX intends to use the payment from Novo to advance the development of its vaccine pipeline. The deal is expected to be closed by the end of this year.

Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It

10:05am, Thursday, 05'th Dec 2024

Zacks.com users have recently been watching Novo Nordisk (NVO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Novo Nordisk to cut US list prices of two insulin products by more than 70%

08:44am, Thursday, 05'th Dec 2024

Danish drug maker Novo Nordisk said on Thursday it will reduce the U.S. list prices of two insulin products by more than 70% from January of 2026.

Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial

12:06pm, Wednesday, 04'th Dec 2024

Eli Lilly's (LLY) popular weight-loss drug Zepbound outperformed Wegovy, a competitor drug from Danish drugmaker Novo Nordisk (NVO), according to the results of a new clinical study released Wednesday

Stock Of The Day: Where Will The Eli Lilly Rally End?

11:47am, Wednesday, 04'th Dec 2024

Shares of Eli Lilly and Company LLY are trading higher on Wednesday. The company said that its Zepbound drug was more effective in helping adults with obesity lose weight than Novo Nordisk A/S's NVO

Lilly's Zepbound Beats Novo's Wegovy in Weight-Loss Drug Trial

11:41am, Wednesday, 04'th Dec 2024

Eli Lilly & Co. said its weight-loss drug Zepbound outperformed rival Novo Nordisk A/S's Wegovy in the first head-to-head trial of the two blockbusters. In the study sponsored by Lilly, those on Zep

Eli Lilly's Weight-Loss Drug Zepbound Is Better than Novo's Wegovy, Study Finds

07:15am, Wednesday, 04'th Dec 2024

On average, Zepbound led to a superior weight loss of 20.2% compared to 13.7% with Wegovy, Lilly said.

Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial

06:45am, Wednesday, 04'th Dec 2024

Eli Lilly said its obesity drug Zepbound led to more weight loss than its main rival, Novo Nordisk's Wegovy, in the first head-to-head clinical trial on the two weekly injections. The findings sugge

Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln

03:03am, Wednesday, 04'th Dec 2024

COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker Novo Nordisk for $200 million and use the proceeds for its vaccine pipeline.

Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum

09:15am, Tuesday, 03'rd Dec 2024

On Tuesday, Defiance ETFs introduced NVOX, the first single-stock leveraged ETF focused on Danish pharmaceutical giant Novo Nordisk A/S NVO.

Novo Nordisk to present new data from sickle cell disease and haemophilia trials at the 66th American Society of Hematology (ASH) annual meeting

08:00am, Tuesday, 03'rd Dec 2024

Bagsværd, Denmark, 3 December 2024 – Novo Nordisk today announced the presentation of 13 abstracts, three of which will be presented in oral sessions, at the upcoming 66th Annual Meeting and Exposi

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by